Iwein Gyselinck, ERS 2021: DAWn-AZITHRO – Azithromycin for Patients with COVID-19
Access all of the content
TouchRESPIRATORY got the opportunity to catch up with Dr Iwein Gyselinck around the DAWn-AZITHRO trial of azithromycin antiviral therapy for patients with COVID-19.
The abstract ‘Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial.’ (Presentation ID 2666) was presented at ERS International Congress 2021, 5-8 September 2021.
- Why has the search for an effective direct acting antiviral for COVID-19 been so challenging? (0:19)
- How has the design of the DAWn-studies sought to overcome these challenges? (1:32)
- What is known about the potential of azithromycin as an antiviral therapy for patients with COVID-19? (2:43)
- What are the aims, methodology and inclusion criteria of the DAWn-AZITHRO study? (3:41)
- What is the primary outcome measure and what were the findings presented at ERS? (5:01)
Disclosures: Iwein Gyselinck has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ERS 2021 (Virtual).
Share this Video
Related Videos In COVID-19
Margaret Pisani, Research highlights in COVID-19 from 2022
Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]
Alan Kaplan: IPCRG COVID-19 and Respiratory Q&A – COVID-19 Controversies, Vaccination and Booster Doses
The IPCRG COVID-19 and Respiratory Q&A is providing evidence based COVID and respiratory advice to practising primary care clinicians. Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) answers questions from the Q&A on managing COVID-19, how to address the controversies surrounding the COVID-19 vaccines, and the immunity provided from COVID-19 vaccination and booster doses. […]
Fiona Mosgrove: IPCRG COVID-19 and Respiratory Q&A – a Focus on COVID-19
touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments for COVID-19 and what will happen as we move out of the pandemic. Questions Could you give […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!